[Federal Register: September 10, 1999 (Volume 64, Number 175)] [Notices] [Page 49203] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr10se99-128] [[Page 49203]] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel HIV Vaccine Design and Development Teams. Date: October 20-21, 1999. Time: 8:30 AM to 5:30 PM. Agenda: To review and evaluate contract proposals. Place: Holiday Inn Bethesda, Maryland Room, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kevin W. Ryan, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2217, 6700-B Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-2550. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research, 93.856, Microbiology and Infectious diseases Research, National Institutes of Health, HHS) Dated: August 31, 1999. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. 99-23564 Filed 9-9-99; 8:45 am] BILLING CODE 4140-01-M